Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2016 / Cilt: 21 - Sayı: 1

Pneumococcal and Influenza Vaccination Coverage Rates of Adult Patients at Risk and Their Attitudes Towards Vaccination

Risk Altındaki Erişkinlerin Pnömokok ve İnfluenza Aşılanma Oranları ve Aşıya Karşı Tutumları

Pages
15–20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Raising awareness of healthcare providers and making them use every visit as an opportunity for vaccination would be effective to improve vaccination coverage rates for adults.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Pneumococcal and influenza infections are important sources of morbidity and mortality in older adults and high-risk persons.
📊
Key Findings & Data:In this study, we aimed to investigate the vaccination coverage rates of the patients, who were hospitalized at an acute care unit and their attitudes towards vaccination.
💡
Conclusion & Impact:Raising awareness of healthcare providers and making them use every visit as an opportunity for vaccination would be effective to improve vaccination coverage rates for adults.
🔬Design:Survey & Empirical Study
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Pneumococcal and influenza infections are important sources of morbidity and mortality in older adults and high-risk persons. Although the efficacy and cost effectiveness of pneumococcal and influenza vaccines were shown by many studies, vaccination coverage of high-risk adults still remains low. In this study, we aimed to investigate the vaccination coverage rates of the patients, who were hospitalized at an acute care unit and their attitudes towards vaccination. Patients and Methods: A prospective observational study was done between November 2014-July 2015. A questionnaire, including their demographical characteristics, co morbidities, influenza and pneumococcal vaccination statuses and their attitudes towards vaccination was conducted on the patients admitted to the acute care unit. Their risk factors for vaccination indications were assessed. Results: 155 patients were enrolled to the study. The median age of the patients was 70 (18-91), and 41.3% of the patients were male. 93.5% of the patients had indication for both influenza and pneumococcal vaccination. Only 17.2% of the patients who had pneumococcal vaccination indication, and 29.7% of the patients who had influenza vaccination indication, were vaccinated. We found that recommendation to the vaccinated patients was mostly made by doctors from secondary or tertiary care rather than primary care doctors. The most common reason for not getting the vaccines was lack of knowledge of the patients. Conclusion: Influenza and pneumococcal vaccination indication rates were high in patients admitted to the acute care unit. In this study, we found that vaccination coverage rates are still low, there is a lack of knowledge of the patients and the doctors are not recommending vaccination to their patients. Raising awareness of healthcare providers and making them use every visit as an opportunity for vaccination would be effective to improve vaccination coverage rates for adults.

Özet

Giriş: İnfluenza ve pnömokok infeksiyonları özellikle yaşlılarda ve yüksek riskli erişkinlerde önemli morbidite ve mortaliteye sebep olmaktadır. İnfluenza ve pnömokok aşılarının etkili ve maliyet-etkin olduğu yapılan çalışmalarla gösterilmiş olmasına rağmen risk altındaki erişkinlerin aşılanma oranları halen düşüktür. Biz bu çalışmamızda bir iç hastalıkları servisine yatırılan hastaların aşılanma oranları ve aşıya karşı tutumlarını araştırmayı amaçladık.Hastalar ve Metod: Bu amaçla Kasım 2014-Temmuz 2015 tarihleri arasında prospektif gözlemsel bir çalışma yapıldı. Akut bakım servisine yatırılan hastalara demografik özellikleri, komorbiditeleri, influenza ve pnömokok aşı durumları ve bu aşılara karşı algı, tutumlarına ilişkin bir anket uygulandı. Her iki aşı için endikasyon oluşturan risk faktörleri sorgulandı.Bulgular: Çalışmaya 155 hasta dahil edildi. Hastaların yaş ortalaması 70 yıl, erkek hastaların oranı %41.3 idi. Hastaların %93.5 (n= 145)'inin hem pnömokok hem de influenza aşısı endikasyonu olduğu saptandı. Pnömokok aşısı endikasyonu olan hastaların sadece %17.2'si aşı olmuşken, influenza aşı endikasyonu olan hastaların aşılanma oranı %29.7 olarak bulundu. Aşı olan hastalara sorulduğunda; her iki aşıyı da en çok aile hekimi dışındaki hekimlerin önermesi sonucunda yaptırdıkları saptandı. Hastaların aşı olmama sebeplerinin başında bilgi yetersizliği gelmekteydi.Sonuç: Poliklinikte olduğu gibi yatan hastalarımızda da influenza ve pnömokok aşı endikasyon oranı oldukça yüksektir. Bu çalışma erişkinler için aşılanma oranlarının halen düşük olduğunu, hastaların bu konuda yeterince bilgi sahibi olmadığını ve hekimlerin gerektiğinde öneride bulunmadıklarını göstermiştir. Hekimlerin bu konuda farkındalığını artırmak ve her başvuruyu bir fırsat olarak değerlendirmelerini sağlamak erişkin aşılama oranlarının artırılmasına önemli ölçüde katkı sağlayacaktır.

🔖

Cite This Article

ÖZIŞIK, L., YEKEDÜZ, E., TANRIÖVER, M. D., HELVACI, Ö., BAŞARAN, N. Ç., ÜNAL, S. (2016). Pneumococcal and Influenza Vaccination Coverage Rates of Adult Patients at Risk and Their Attitudes Towards Vaccination. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 21 - Sayı: 1, 15–20. https://ajindex.com/articles/197424

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Estimates of deaths associated with seasonal influenzaUnited States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010;59:1057-62
  2. Appiah GD, Blanton L, D'Mello T, Kniss K, Smith S, Mustaquim D, et al. Influenza activity-United States, 2014-15 season and composition of the 2015-16 influenza vaccine. MMWR Morb Mortal Wkly Rep 2015;64:583-90
  3. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011;29:3398-412
  4. Centers for Disease Control and Prevention. 2014. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2014
  5. Ministry of Health Refik Saydam Hygiene Center Presidency School of Public Health: National burden of disease and cost effectiveness project: Burden of disease final report. 2004, http://www.toraks.org.tr/userfiles/file/ulusal_hastalik_yuku_ burdenofdiseaseENG.pdf 6. Esel D, Doganay M, Alp E, Sumerkan B. Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome. Clin Microbiol Infect 2003;9:1038-44
  6. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013;62(RR-07):1-43
  7. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. In: KA Hamborsky J, Wolfe S (eds). Washington DC: Public Health Foundation, 2015
  8. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, in Pneumococcal Disease. In: KA Hamborsky J, Wolfe S (eds). Washington DC: Public Health Foundation, 2015
  9. Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015;372:1114-25
  10. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. Costeffectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med 2001;161:111-20
  11. Akin L, Kaya M, Altinel S, Durand L. Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey. Hum Vaccin 2011;7:441-50
  12. Kim DK, Bridges CB, Harriman KH. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older-United States, 2015. MMWR Morb Mortal Wkly Rep 20